Rossi, Marcello
Rossi, Marcello
Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration
2020 Saijo, E.; Metrick, M. A.; Koga, S.; Parchi, P.; Litvan, I.; Spina, S.; Boxer, A.; Rojas, J. C.; Galasko, D.; Kraus, A.; Rossi, M.; Newell, K.; Zanusso, G.; Grinberg, L. T.; Seeley, W. W.; Ghetti, B.; Dickson, D. W.; Caughey, B.
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease
2025 Bernhardt, Alexander M.; Longen, Sebastian; Trossbach, Svenja V.; Rossi, Marcello; Weckbecker, Daniel; Schmidt, Felix; Jäck, Alexander; Katzdobler, Sabrina; Fietzek, Urban M.; Weidinger, Endy; Palleis, Carla; Ruf, Viktoria; Baiardi, Simone; Parchi, Piero; Höglinger, Günter U.; Matthias, Torsten; Levin, Johannes; Giese, Armin
Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients
2025 Emmi, A.; Mammana, A.; Sandre, M.; Baiardi, S.; Weis, L.; Rossi, M.; Magliocchetti, F.; Savarino, E.; Russo, F. P.; Porzionato, A.; Carecchio, M.; Campagnolo, M.; Antonini, A.; Parchi, P.
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum
2025 Mastrangelo, A.; Mammana, A.; Hall, S.; Stomrud, E.; Zenesini, C.; Rossi, M.; Janelidze, S.; Ticca, A.; Palmqvist, S.; Magliocchetti, F.; Baiardi, S.; Mattsson-Carlgren, N.; Hansson, O.; Parchi, P.
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias
2019 Baiardi, S.; Abu-Rumeileh, S.; Rossi, M.; Zenesini, C.; Bartoletti-Stella, A.; Polischi, B.; Capellari, S.; Parchi, P.
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies
2021 Brockmann, K.; Quadalti, C.; Lerche, S.; Rossi, M.; Wurster, I.; Baiardi, S.; Roeben, B.; Mammana, A.; Zimmermann, M.; Hauser, A. -K.; Deuschle, C.; Schulte, C.; Waniek, K.; Lachmann, I.; Sjodin, S.; Brinkmalm, A.; Blennow, K.; Zetterberg, H.; Gasser, T.; Parchi, P.
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo
2024 Pichet Binette, A.; Mammana, A.; Wisse, L.; Rossi, M.; Strandberg, O.; Smith, R.; Mattsson-Carlgren, N.; Janelidze, S.; Palmqvist, S.; Ticca, A.; Stomrud, E.; Parchi, P.; Hansson, O.
Atypical creutzfeldt-jakob disease with prpamyloid plaques in white matter: Molecular characterization and transmission to bank voles show the M1 strain signature
2017 Rossi, M.; Saverioni, D.; Di Bari, M.; Baiardi, S.; Lemstra, A. W.; Pirisinu, L.; Capellari, S.; Rozemuller, A.; Nonno, R.; Parchi, P.
Clinical effects of Lewy body pathology in cognitively impaired individuals
2023 Quadalti, C.; Palmqvist, S.; Hall, S.; Rossi, M.; Mammana, A.; Janelidze, S.; Dellavalle, S.; Mattsson-Carlgren, N.; Baiardi, S.; Stomrud, E.; Hansson, O.; Parchi, P.
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?
2024 Bentivenga, G. M.; Baiardi, S.; Mastrangelo, A.; Ruggeri, E.; Mammana, A.; Ticca, A.; Rossi, M.; Capellari, S.; Parchi, P.
Cognitive effects of Lewy body pathology in clinically unimpaired individuals
2023 Palmqvist, S.; Rossi, M.; Hall, S.; Quadalti, C.; Mattsson-Carlgren, N.; Dellavalle, S.; Tideman, P.; Pereira, J. B.; Nilsson, M. H.; Mammana, A.; Janelidze, S.; Baiardi, S.; Stomrud, E.; Parchi, P.; Hansson, O.
Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt–Jakob Disease Surveillance Network
2022 Mckenzie, N.; Piconi, G.; Culeux, A.; Hammarin, A. -L.; Stergiou, C.; Tzartos, S.; Versleijen, A. A. M.; Van De Geer, J.; Cras, P.; Cardone, F.; Ladogana, A.; Mannana, A.; Rossi, M.; Bongianni, M.; Perra, D.; Regelsberger, G.; Klotz, S.; Hornemann, S.; Aguzzi, A.; Schmitz, M.; Andrews, M.; Burns, K.; Haik, S.; Ruiz-Garcia, R.; Verner-Carlsson, J.; Tzartos, J.; Verbeek, M. M.; De Vil, B.; Poleggi, A.; Parchi, P.; Zanusso, G.; Gelpi, E.; Frontzek, K.; Reimann, R.; Hermann, P.; Zerr, I.; Pal, S.; Green, A.
CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder
2024 Munoz-Lopetegi, A.; Baiardi, S.; Balasa, M.; Mammana, A.; Maya, G.; Rossi, M.; Serradell, M.; Zenesini, C.; Ticca, A.; Santamaria, J.; Dellavalle, S.; Gaig, C.; Iranzo, A.; Parchi, P.
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
2024 Brockmann, K.; Lerche, S.; Baiardi, S.; Rossi, M.; Wurster, I.; Quadalti, C.; Roeben, B.; Mammana, A.; Zimmermann, M.; Hauser, A. -K.; Deuschle, C.; Schulte, C.; Liepelt-Scarfone, I.; Gasser, T.; Parchi, P.
Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type
2023 Baiardi, S.; Mammana, A.; Dellavalle, S.; Rossi, M.; Redaelli, V.; Colaizzo, E.; Di Fede, G.; Ladogana, A.; Capellari, S.; Parchi, P.
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients
2020 Mammana, A.; Baiardi, S.; Rossi, M.; Franceschini, A.; Donadio, V.; Capellari, S.; Caughey, B.; Parchi, P.
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia
2024 Bentivenga, G. M.; Baiardi, S.; Mastrangelo, A.; Zenesini, C.; Mammana, A.; Rossi, M.; Polischi, B.; Capellari, S.; Parchi, P.
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies
2021 Rossi, M.; Baiardi, S.; Teunissen, C. E.; Quadalti, C.; Van De Beek, M.; Mammana, A.; Stanzani-Maserati, M.; Van Der Flier, W. M.; Sambati, L.; Zenesini, C.; Caughey, B.; Capellari, S.; Lemstra, A. W.; Parchi, P.
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants
2025 Lerche, Stefanie; Wurster, Isabel; Roeben, Benjamin; Zimmermann, Milan; Rossi, Marcello; Mammana, Angela; Baiardi, Simone; Hauser, Ann‑kathrin; Deuschle, Christian; Schulte, Claudia; Parchi, Piero; Brockmann, Kathrin
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: A 10-year study in Italy
2022 Mastrangelo, A.; Mammana, A.; Baiardi, S.; Tiple, D.; Colaizzo, E.; Rossi, M.; Vaianella, L.; Polischi, B.; Equestre, M.; Poleggi, A.; Capellari, S.; Ladogana, A.; Parchi, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration | 1-gen-2020 | Saijo, E.; Metrick, M. A.; Koga, S.; Parchi, P.; Litvan, I.; Spina, S.; Boxer, A.; Rojas, J. C.; Galasko, D.; Kraus, A.; Rossi, M.; Newell, K.; Zanusso, G.; Grinberg, L. T.; Seeley, W. W.; Ghetti, B.; Dickson, D. W.; Caughey, B. | |
| A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease | 1-gen-2025 | Bernhardt, Alexander M.; Longen, Sebastian; Trossbach, Svenja V.; Rossi, Marcello; Weckbecker, Daniel; Schmidt, Felix; Jäck, Alexander; Katzdobler, Sabrina; Fietzek, Urban M.; Weidinger, Endy; Palleis, Carla; Ruf, Viktoria; Baiardi, Simone; Parchi, Piero; Höglinger, Günter U.; Matthias, Torsten; Levin, Johannes; Giese, Armin | |
| Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients | 1-gen-2025 | Emmi, A.; Mammana, A.; Sandre, M.; Baiardi, S.; Weis, L.; Rossi, M.; Magliocchetti, F.; Savarino, E.; Russo, F. P.; Porzionato, A.; Carecchio, M.; Campagnolo, M.; Antonini, A.; Parchi, P. | |
| Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum | 1-gen-2025 | Mastrangelo, A.; Mammana, A.; Hall, S.; Stomrud, E.; Zenesini, C.; Rossi, M.; Janelidze, S.; Ticca, A.; Palmqvist, S.; Magliocchetti, F.; Baiardi, S.; Mattsson-Carlgren, N.; Hansson, O.; Parchi, P. | |
| Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias | 1-gen-2019 | Baiardi, S.; Abu-Rumeileh, S.; Rossi, M.; Zenesini, C.; Bartoletti-Stella, A.; Polischi, B.; Capellari, S.; Parchi, P. | |
| Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies | 1-gen-2021 | Brockmann, K.; Quadalti, C.; Lerche, S.; Rossi, M.; Wurster, I.; Baiardi, S.; Roeben, B.; Mammana, A.; Zimmermann, M.; Hauser, A. -K.; Deuschle, C.; Schulte, C.; Waniek, K.; Lachmann, I.; Sjodin, S.; Brinkmalm, A.; Blennow, K.; Zetterberg, H.; Gasser, T.; Parchi, P. | |
| Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo | 1-gen-2024 | Pichet Binette, A.; Mammana, A.; Wisse, L.; Rossi, M.; Strandberg, O.; Smith, R.; Mattsson-Carlgren, N.; Janelidze, S.; Palmqvist, S.; Ticca, A.; Stomrud, E.; Parchi, P.; Hansson, O. | |
| Atypical creutzfeldt-jakob disease with prpamyloid plaques in white matter: Molecular characterization and transmission to bank voles show the M1 strain signature | 1-gen-2017 | Rossi, M.; Saverioni, D.; Di Bari, M.; Baiardi, S.; Lemstra, A. W.; Pirisinu, L.; Capellari, S.; Rozemuller, A.; Nonno, R.; Parchi, P. | |
| Clinical effects of Lewy body pathology in cognitively impaired individuals | 1-gen-2023 | Quadalti, C.; Palmqvist, S.; Hall, S.; Rossi, M.; Mammana, A.; Janelidze, S.; Dellavalle, S.; Mattsson-Carlgren, N.; Baiardi, S.; Stomrud, E.; Hansson, O.; Parchi, P. | |
| Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? | 1-gen-2024 | Bentivenga, G. M.; Baiardi, S.; Mastrangelo, A.; Ruggeri, E.; Mammana, A.; Ticca, A.; Rossi, M.; Capellari, S.; Parchi, P. | |
| Cognitive effects of Lewy body pathology in clinically unimpaired individuals | 1-gen-2023 | Palmqvist, S.; Rossi, M.; Hall, S.; Quadalti, C.; Mattsson-Carlgren, N.; Dellavalle, S.; Tideman, P.; Pereira, J. B.; Nilsson, M. H.; Mammana, A.; Janelidze, S.; Baiardi, S.; Stomrud, E.; Parchi, P.; Hansson, O. | |
| Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt–Jakob Disease Surveillance Network | 1-gen-2022 | Mckenzie, N.; Piconi, G.; Culeux, A.; Hammarin, A. -L.; Stergiou, C.; Tzartos, S.; Versleijen, A. A. M.; Van De Geer, J.; Cras, P.; Cardone, F.; Ladogana, A.; Mannana, A.; Rossi, M.; Bongianni, M.; Perra, D.; Regelsberger, G.; Klotz, S.; Hornemann, S.; Aguzzi, A.; Schmitz, M.; Andrews, M.; Burns, K.; Haik, S.; Ruiz-Garcia, R.; Verner-Carlsson, J.; Tzartos, J.; Verbeek, M. M.; De Vil, B.; Poleggi, A.; Parchi, P.; Zanusso, G.; Gelpi, E.; Frontzek, K.; Reimann, R.; Hermann, P.; Zerr, I.; Pal, S.; Green, A. | |
| CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder | 1-gen-2024 | Munoz-Lopetegi, A.; Baiardi, S.; Balasa, M.; Mammana, A.; Maya, G.; Rossi, M.; Serradell, M.; Zenesini, C.; Ticca, A.; Santamaria, J.; Dellavalle, S.; Gaig, C.; Iranzo, A.; Parchi, P. | |
| CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease | 1-gen-2024 | Brockmann, K.; Lerche, S.; Baiardi, S.; Rossi, M.; Wurster, I.; Quadalti, C.; Roeben, B.; Mammana, A.; Zimmermann, M.; Hauser, A. -K.; Deuschle, C.; Schulte, C.; Liepelt-Scarfone, I.; Gasser, T.; Parchi, P. | |
| Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type | 1-gen-2023 | Baiardi, S.; Mammana, A.; Dellavalle, S.; Rossi, M.; Redaelli, V.; Colaizzo, E.; Di Fede, G.; Ladogana, A.; Capellari, S.; Parchi, P. | |
| Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients | 1-gen-2020 | Mammana, A.; Baiardi, S.; Rossi, M.; Franceschini, A.; Donadio, V.; Capellari, S.; Caughey, B.; Parchi, P. | |
| Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia | 1-gen-2024 | Bentivenga, G. M.; Baiardi, S.; Mastrangelo, A.; Zenesini, C.; Mammana, A.; Rossi, M.; Polischi, B.; Capellari, S.; Parchi, P. | |
| Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies | 1-gen-2021 | Rossi, M.; Baiardi, S.; Teunissen, C. E.; Quadalti, C.; Van De Beek, M.; Mammana, A.; Stanzani-Maserati, M.; Van Der Flier, W. M.; Sambati, L.; Zenesini, C.; Caughey, B.; Capellari, S.; Lemstra, A. W.; Parchi, P. | |
| Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants | 1-gen-2025 | Lerche, Stefanie; Wurster, Isabel; Roeben, Benjamin; Zimmermann, Milan; Rossi, Marcello; Mammana, Angela; Baiardi, Simone; Hauser, Ann‑kathrin; Deuschle, Christian; Schulte, Claudia; Parchi, Piero; Brockmann, Kathrin | |
| Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: A 10-year study in Italy | 1-gen-2022 | Mastrangelo, A.; Mammana, A.; Baiardi, S.; Tiple, D.; Colaizzo, E.; Rossi, M.; Vaianella, L.; Polischi, B.; Equestre, M.; Poleggi, A.; Capellari, S.; Ladogana, A.; Parchi, P. |
